Printer Friendly

Research and Markets: Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2012.

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/dvgsx2/graft_versus_host) has announced the addition of Global Markets Direct's new report "Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2012" to their offering.

Global Markets Direct's, 'Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2012', provides an overview of the Graft Versus Host Disease (GVHD) therapeutic pipeline. This report provides information on the therapeutic development for Graft Versus Host Disease (GVHD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Graft Versus Host Disease (GVHD). 'Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A snapshot of the global therapeutic scenario for Graft Versus Host Disease (GVHD).

- A review of the Graft Versus Host Disease (GVHD) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Graft Versus Host Disease (GVHD) pipeline on the basis of route of administration and molecule type.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Graft Versus Host Disease (GVHD).

- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.

- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.

Keywords

Graft Versus Host Disease (GVHD) Therapeutic Products under Development, Key Players in Graft Versus Host Disease (GVHD) Therapeutics, Graft Versus Host Disease (GVHD) Pipeline Overview, Graft Versus Host Disease (GVHD) Pipeline, Graft Versus Host Disease (GVHD) Pipeline Assessment

For more information visit http://www.researchandmarkets.com/research/dvgsx2/graft_versus_host

Source: Global Markets Direct
COPYRIGHT 2012 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Report
Date:May 30, 2012
Words:413
Previous Article:Finish Line Employees to Volunteer at Special Olympics Indiana Summer Games.
Next Article:Research and Markets: European Gigabit Ethernet Test Equipment Market.
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters